Acute Exacerbations of Idiopathic Pulmonary Fibrosis

Harold R. Collard(San Francisco General Hospital), Bethany B. Moore(University of Michigan), Kevin R. Flaherty(University of Michigan), Kevin M. Brown(National Jewish Health), Robert J. Kaner(Cornell University), Talmadge E. King(San Francisco General Hospital), Joseph A. Lasky(Tulane University), James E. Loyd(Vanderbilt University), Imre Noth(University of Chicago), Mitchell A. Olman(University of Alabama at Birmingham), Ganesh Raghu(University of Washington), Jesse Roman(Emory University), Jay H. Ryu(Mayo Clinic), David A. Zisman(University of California, Los Angeles), Gary W. Hunninghake(University of Iowa), Thomas V. Colby(Mayo Clinic in Arizona), Jim Egan(University College Dublin), David M. Hansell(Royal Brompton Hospital), Takeshi Johkoh(The University of Osaka), Naftali Kaminski(University of Pittsburgh), Dong Soon Kim(Asan Medical Center), Yasuhiro Kondoh(Tosei General Hospital), David A. Lynch(National Jewish Health), Joachim Müller–Quernheim(University of Freiburg), Jeffrey L. Myers(University of Michigan), Andrew G. Nicholson(Royal Brompton Hospital), Moisés Selman(Instituto Nacional de Enfermedades Respiratorias), Galen B. Toews(University of Michigan), Athol U. Wells(Royal Brompton Hospital), Fernando J. Martínez(University of Michigan)
American Journal of Respiratory and Critical Care Medicine
June 21, 2007
Cited by 1,123Open Access
Full Text

Abstract

The natural history of idiopathic pulmonary fibrosis (IPF) has been characterized as a steady, predictable decline in lung function over time. Recent evidence suggests that some patients may experience a more precipitous course, with periods of relative stability followed by acute deteriorations in respiratory status. Many of these acute deteriorations are of unknown etiology and have been termed acute exacerbations of IPF. This perspective is the result of an international effort to summarize the current state of knowledge regarding acute exacerbations of IPF. Acute exacerbations of IPF are defined as acute, clinically significant deteriorations of unidentifiable cause in patients with underlying IPF. Proposed diagnostic criteria include subjective worsening over 30 days or less, new bilateral radiographic opacities, and the absence of infection or another identifiable etiology. The potential pathobiological roles of infection, disordered cell biology, coagulation, and genetics are discussed, and future research directions are proposed.


Related Papers

No related papers found

Powered by citation graph analysis